Allegro is currently conducting pre-clinical tests on the Meniscus project and other candidates in the INTRICATE program.
We are committed to improving the lives of people suffering from traumatic injuries and degenerative disease. We aim to do this in partnership; by listening to patients, supporters and advocacy communities and hearing your stories. It is your words and your resilience that motivate us to advance the understanding of rare disease and work to deliver new treatments to as many patients as possible.